Clinical Trials Directory

Trials / Completed

CompletedNCT04289545

Postprandial Effects of Functional Bread

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Bergen · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study investigates whether bread with added galactomannan, a soluble fiber, can reduce the postprandial glucose response in healthy overweight adults.

Detailed description

This single-blind crossover-designed study wants to investigate the postprandial effect of functional bread in healthy overweight adults. Therefore, four types of bread, consumed by the participants, have added galactomannan in different amounts and viscosities, and one bread is the control bread. The participants arrive after an overnight fast and before the consumption of bread, a fasting blood sample is taken. After the ingestion, blood samples are taken at specific times. The area under the curve of the postprandial glucose is expected to differ between the functional breads.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFunctional breadPostprandial effects of bread containing galactomannan

Timeline

Start date
2019-11-01
Primary completion
2021-07-07
Completion
2021-07-07
First posted
2020-02-28
Last updated
2021-07-19

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04289545. Inclusion in this directory is not an endorsement.